Study reveals how gene activity shapes immunity across species

More than 250,000 single cells studied to chart evolution of antiviral and antibacterial immunity

Study reveals how gene activity shapes immunity across species

Body image 400x400px.jpg
Researchers studied the gene activity from over 250,000 single cells - fibroblasts and phagocytes - to show how the innate immune response varies between cells and species.

By sequencing genes from over a quarter of a million cells across six mammalian species, researchers at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute and collaborators, have shown how genes in the immune response have varied activity between cells and species.

The study, published today (24 October) in Nature, looked in unprecedented detail at the genes that are activated in a cell’s initial response to a pathogen invasion – the innate immune response. They measured the activity of thousands of genes in over 250,000 individual cells using single cell genomics technology to chart the evolution of antiviral and antibacterial immunity.

Previous work has shown that many genes in the innate immune response have rapidly evolved in vertebrates. This is thought to be caused by the relentless pressure of attack from pathogens like bacteria and viruses. These include genes that make cytokine and chemokine molecules, which act in a variety of ways – some are inflammatory molecules that alert the body to danger; others restrict a pathogen’s ability to multiply and others induce cell death. They represent a successful host strategy to counteract rapidly evolving pathogens.

The team showed that these genes which have evolved rapidly across species, also have highly variable activity in different cells within an individual’s tissue.

In contrast, they found that genes which are conserved between species, and regulate the immune response, are more consistently activated across cells within a tissue. These genes may be under tighter constraints because they are involved in many different functions within cells. But, they are also targeted by viruses. These constrained genes represent an Achilles’ heel, used by pathogens to subvert the immune system.

“We think that this pattern of activation – where some genes are under tight control, and others have more variable activity - has evolved as a way to fine-tune the immune response. It is effective, but balanced. Genes can evolve to help a cell control an attacker, and the use of those genes can vary between cells, so surrounding tissues are not affected by a massive fall-out.”

Dr Tzachi Hagai, lead author of the research at the Wellcome Sanger Institute

“The power of DNA sequencing at the resolution of single cells means this kind of study is now possible. There are an estimated 37 trillion cells in the human body, each with the same genetic code. But individual cells behave differently, they use that genetic code in a different way. By studying individual cells we can understand these fundamental building blocks of life and how they work together – including how they resist pathogens.”

Dr Sarah Teichmann, Head of Cellular Genetics at the Wellcome Sanger Institute and senior author of the research

Notes to Editors

Tzachi Hagai et al. (2018) Gene expression variability across cells and species shapes innate immunity. Nature. DOI: 10.1038/s41586-018-0657-2


This project was supported by ERC grants (ThDEFINE, ThSWITCH) and an EU FET-OPEN grant (MRG-GRAMMAR No 664918), Wellcome Sanger core funding (Grant No WT206194), a HFSP Long-Term Fellowship, EMBO Long-Term and Advanced fellowships and Fondazione Umberto Veronesi.

Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7748 379849

Recent News

Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
Pan-Cancer Project discovers causes of previously unexplained cancers, pinpoints cancer-causing events and zeroes in on mechanisms of development
Comprehensive study finds mutations in non-coding genome are infrequent drivers of cancer
Findings suggest efforts to develop new cancer treatments should primarily focus on protein-coding genes